Catalyst Wire Dossier Catalyst Wire Dossier
FDA approval · 2011-05-09

FDA Approved: FAMCICLOVIR — Supplemental Application (Teva Pharmaceuticals USA, Inc.)

View source ↗

Summary

FDA approved a supplemental application for famciclovir from Teva Pharmaceuticals USA, Inc., updating the regulatory status for the generic product.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Famciclovir (famciclovir)

Snippet

SUPPL AP for FAMCICLOVIR (FAMCICLOVIR)